JP2016511281A5 - - Google Patents

Download PDF

Info

Publication number
JP2016511281A5
JP2016511281A5 JP2015562366A JP2015562366A JP2016511281A5 JP 2016511281 A5 JP2016511281 A5 JP 2016511281A5 JP 2015562366 A JP2015562366 A JP 2015562366A JP 2015562366 A JP2015562366 A JP 2015562366A JP 2016511281 A5 JP2016511281 A5 JP 2016511281A5
Authority
JP
Japan
Prior art keywords
erythro
benzoyl
under conditions
conditions effective
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015562366A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016511281A (ja
JP6438417B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/000494 external-priority patent/WO2014140787A2/en
Publication of JP2016511281A publication Critical patent/JP2016511281A/ja
Publication of JP2016511281A5 publication Critical patent/JP2016511281A5/ja
Application granted granted Critical
Publication of JP6438417B2 publication Critical patent/JP6438417B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015562366A 2013-03-15 2014-03-14 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法 Active JP6438417B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361801641P 2013-03-15 2013-03-15
US61/801,641 2013-03-15
EP13306056.6 2013-07-23
EP13306056 2013-07-23
PCT/IB2014/000494 WO2014140787A2 (en) 2013-03-15 2014-03-14 Methods for the synthesis of sphingomyelins and dihydrosphingomyelins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018117808A Division JP2018168171A (ja) 2013-03-15 2018-06-21 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Publications (3)

Publication Number Publication Date
JP2016511281A JP2016511281A (ja) 2016-04-14
JP2016511281A5 true JP2016511281A5 (enExample) 2017-02-02
JP6438417B2 JP6438417B2 (ja) 2018-12-12

Family

ID=51538203

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015562366A Active JP6438417B2 (ja) 2013-03-15 2014-03-14 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法
JP2018117808A Pending JP2018168171A (ja) 2013-03-15 2018-06-21 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018117808A Pending JP2018168171A (ja) 2013-03-15 2018-06-21 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Country Status (16)

Country Link
US (3) US20140316154A1 (enExample)
EP (3) EP2970344A2 (enExample)
JP (2) JP6438417B2 (enExample)
KR (1) KR20150132188A (enExample)
CN (1) CN105051051B (enExample)
AU (2) AU2014229638B2 (enExample)
BR (1) BR112015023558A2 (enExample)
CA (1) CA2900902C (enExample)
DK (1) DK3363805T3 (enExample)
ES (1) ES3017659T3 (enExample)
HK (1) HK1214266A1 (enExample)
MX (1) MX387128B (enExample)
PH (1) PH12015501835A1 (enExample)
SG (2) SG11201506456VA (enExample)
WO (1) WO2014140787A2 (enExample)
ZA (1) ZA201505860B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010213568B2 (en) 2009-02-16 2014-11-20 Cerenis Therapeutics Holding Sa Apolipoprotein A-I Mimics
CN106167483B (zh) 2010-10-18 2019-02-15 塞伦尼斯医疗控股有限公司 可用于胆固醇动员的化合物、组合物和方法
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
JP6438417B2 (ja) * 2013-03-15 2018-12-12 セレニス セラピューティクス ホールディング エスアー スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法
WO2019030575A1 (en) 2017-08-10 2019-02-14 Cerenis Therapeutics Holding APOMÈRES
WO2019030574A1 (en) 2017-08-10 2019-02-14 Cerenis Therapeutics Holding Cargomers
WO2019189133A1 (ja) * 2018-03-27 2019-10-03 日油株式会社 スフィンゴミエリン誘導脂質およびその製造方法
JP7303618B2 (ja) * 2018-10-05 2023-07-05 日本精化株式会社 スフィンゴリン脂質前駆体及びその製造方法、並びに、スフィンゴリン脂質の製造方法
IL297336A (en) 2020-04-16 2022-12-01 Abionyx Pharma Sa Methods for treating acute conditions using lipid binding protein-based complexes
CN115666720A (zh) 2020-04-16 2023-01-31 阿比奥尼克斯制药公司 用于治疗肾病的cer-001疗法
WO2021209808A1 (en) 2020-04-16 2021-10-21 Abionyx Pharma Sa Cer-001 therapy for treating kidney disease
KR20230079132A (ko) 2020-10-01 2023-06-05 아비오닉스 파마 에스에이 안질환을 치료하는 데 사용하기 위한 지질 결합 단백질-기반 복합체를 포함하는 조성물
AU2022258815A1 (en) 2021-04-15 2023-10-19 Abionyx Pharma Sa Use of lipid binding protein-based complexes in organ preservation solutions
KR20240167701A (ko) 2022-04-06 2024-11-27 아비오닉스 파마 에스에이 지질 결합 단백질-기반 복합체를 사용하여 안질환을 치료하는 방법
CN119317440A (zh) 2022-04-06 2025-01-14 阿比奥尼克斯制药公司 使用基于脂质结合蛋白的复合物治疗白细胞增多、内皮功能障碍和心脏炎的方法
EP4536269A2 (en) 2022-06-10 2025-04-16 Abionyx Pharma SA Methods for treating acute conditions using lipid binding protein-based complexes
US20250352613A1 (en) 2022-06-10 2025-11-20 Stanislas FAGUER Methods for treating hyperinflammatory conditions using lipid binding protein -based complexes
JP2025521721A (ja) 2022-06-28 2025-07-10 アビオニクス ファーマ エスエー スフィンゴミエリンの合成のための化合物およびプロセス
KR20260010675A (ko) 2023-01-13 2026-01-21 아비오닉스 파마 에스에이 지질 결합 단백질 분자 치료
WO2025093929A1 (en) 2023-10-31 2025-05-08 Abionyx Pharma Sa Lipid binding protein molecule therapy

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146810A3 (de) 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
US5220043A (en) * 1991-03-21 1993-06-15 Ohio University Synthesis of D-erythro-sphingomyelins
JP3002702B2 (ja) 1993-11-16 2000-01-24 スカイファーム インコーポレーテッド 活性物質の制御放出を有する小胞
US5766627A (en) 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
CA2320117A1 (en) 1998-02-12 1999-08-19 Emory University Sphingolipid derivatives and their methods of use
JP2004002215A (ja) * 2002-05-23 2004-01-08 National Institute Of Advanced Industrial & Technology スフィンゴ脂質誘導体の製造方法
AU2005205245A1 (en) 2004-01-15 2005-07-28 Biolab Ltd. Sphingomyelin, intermediates thereof and methods for preparation of same
ATE450251T1 (de) 2004-05-17 2009-12-15 Tekmira Pharmaceuticals Corp Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung
AU2005259501A1 (en) 2004-06-29 2006-01-12 Jado Technologies Gmbh Sphingolipids against pathological processes in lipid rafts
JP4825947B2 (ja) 2004-08-04 2011-11-30 学校法人関西学院 不飽和アミノジオール類の製造方法
JP2006045113A (ja) 2004-08-04 2006-02-16 Kemikurea:Kk リン酸エステル類
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
TWI387603B (zh) * 2005-07-20 2013-03-01 Merck Sharp & Dohme Hcv ns3蛋白酶抑制劑
JP2007204384A (ja) 2006-01-31 2007-08-16 Kemikurea:Kk 光学活性リン酸誘導体およびこれを用いた光学活性スフィンゴシン1−リン酸誘導体の製造方法
WO2008096880A1 (ja) * 2007-02-09 2008-08-14 Gifu University スフィンゴ糖脂質の合成法
US8093395B2 (en) 2007-03-09 2012-01-10 Otsuka Chemical Co., Ltd. Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
AU2009302042A1 (en) 2008-10-07 2010-04-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Liposomal systems comprising sphingomyelin
PT2673296T (pt) 2011-02-07 2019-01-31 Cerenis Therapeutics Holding Sa Complexos de lipoproteínas e sua fabricação e utilização
FR3000959B1 (fr) * 2013-01-14 2015-08-21 Holis Technologies Nouveaux intermediaires de synthese permettant d'acceder avec de bons rendements a des derives de sphingosines, ceramides et sphingomyelines
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
JP6438417B2 (ja) 2013-03-15 2018-12-12 セレニス セラピューティクス ホールディング エスアー スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Similar Documents

Publication Publication Date Title
US9708354B2 (en) Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
CN103842366B (zh) 制备抗病毒核苷酸类似物的方法
EP3077404B1 (en) Purification of tenofovir alafenamide and its intermediates
US20170204122A1 (en) Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
RU2012141048A (ru) Композиция прокатализатора с замещенным амидоэфиром в качестве внутреннего донора электронов
JP2015527345A5 (enExample)
EP3805199A4 (en) PROCESS FOR PREPARATION OF PREGABALIN INTERMEDIATE (R)-3(CARBAMOYLMETHYL)-5-METHYLHEXAID
JP2012500237A5 (enExample)
CA2812178A1 (en) Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof
CN105237560A (zh) 一种lzc696中间体及其合成方法
EP2970102B1 (en) An improved process for the synthesis of melphalan and the hydrochloride salt
JP2018536645A5 (enExample)
JP2012017285A5 (enExample)
JP2017513885A5 (enExample)
JP2019526552A5 (enExample)
EP2385034B1 (en) Process for the preparation of 1-nitro-4-oxobutanylamides
RU2005127872A (ru) Оптически активные соединения бисоксазолина, способ их получения и применение
JP6139694B2 (ja) ホスホン酸モノマーの調製のためのプロセス
Nieves et al. Approaches to polyunsaturated sphingolipids: new conformationally restrained analogs with minimal structural modifications
AR081836A1 (es) Proceso para la produccion de aliskiren, procedimiento para la preparacion de intermediarios para su sintesis y compuestos necesarios para obtener estos ultimos
JP6011999B2 (ja) アミノ酸イオン液体を用いたn−アシルアミノ酸又はn−アシルペプチドの製造方法
CN1871246A (zh) {2-[(8,9)-二氧代-2,6-二氮杂-双环[5.2.0]-壬-1(7)-烯-2-基]乙基}膦酸及其酯的制备方法
Hassanabadi et al. Three-component reaction between trivalent phosphorus nucleophiles, dialkyl acetylenedicarboxylates and (2, 4-dinitrophenyl) acetic acid
RU2024101559A (ru) Дигидро-2н-изоиндольный сложный эфир
JP6426015B2 (ja) 光学活性含フッ素アミン化合物及びその製造方法